✦ LIBER ✦

Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes

✍ Scribed by Takahisa Furuta; Takayuki Iwaki; Kazuo Umemura

Book ID: 108642557
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 1016 KB
Volume: 70
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2010.03717.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of three proton pump in

Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype

✍ Hai-Ling Qiao; Yu-Rong Hu; Xin Tian; Lin-Jing Jia; Na Gao; Li-Rong Zhang; Yu-Zho 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 127 KB

Different effects of fluvoxamine on rabe

Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status

✍ Tsukasa Uno; Mikiko Shimizu; Norio Yasui-Furukori; Kazunobu Sugawara; Tomonori T 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Effect of clarithromycin on the enantios

Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes

✍ Masatomo Miura; Hitoshi Tada; Norio Yasui-Furukori; Tsukasa Uno; Kazunobu Sugawa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

Combined influence of proton-pump inhibi

Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention

✍ A. M. HARMSZE; J. W. VAN WERKUM; P. C. SOUVEREIN; N. J. BREET; H. J. BOUMAN; C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

Effect of an increased clopidogrel maint

Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects

✍ J.-S. HULOT; G. WUERZNER; C. BACHELOT-LOZA; M. AZIZI; A. BLANCHARD; S. PEYRARD; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Pharmacokinetic differences between the

Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes

✍ M. Miura; H. Tada; N. Yasui-Furukori; T. Uno; K. Sugawara; T. Tateishi; T. Suzuk 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 237 KB